跳至主要内容
临床试验/TCTR20191108001
TCTR20191108001已完成未知

A comparative study on level of hepatic steatosis and fibrosis between pre-and post-chelation therapy in patients with chronic lead poisoning

nit of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University0 个研究点目标入组 86 人开始时间: 2019年11月8日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
86

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • For Chonic lead poisoning group
  • - Patients with blood lead level ≥ 70 µg/dl
  • - Exposed to lead ≥ 1 year
  • For controlled group
  • - Patients with blood lead level < 40 µg/dl
  • - Age-sex matched with participants

排除标准

  • - Chronic HBV infection
  • - Chonic HCV infection
  • - Autoimmune hepatitis
  • - Wilsons disease
  • - Hemochromatosis
  • - Alcohol consumption (>= 30 g/day in men, >= 20 g/day in women)
  • - Prior known exposure to hepatotoxicity drugs within 5 years
  • - known history of NAFLD
  • - Diabetes Mellitus

研究者

发起方
nit of Gastroenterology&#44; Department of Medicine&#44; Faculty of Medicine&#44; Chulalongkorn University

相似试验